Medical Devices

Clinical-stage Nyra Medical begins a key U.S. study for its novel mitral valve device, a strategic move challenging established players in a crowded field.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

Presage Technologies' new FDA-cleared app turns any phone into a vital signs monitor, offering it free to hospitals to democratize healthcare access.

Canon's new AI for CT scanners promises near-photon-counting quality. Is this a true leap forward for diagnostics or a clever stopgap in a competitive market?

For millions with the debilitating condition dysautonomia, diagnosis is a long, frustrating journey. A new technology promises to replace subjective guesswork with hard data.

With its first FDA clearance, Movmedix introduces a synthetic ligament used in 250,000+ global procedures. But can it win over a U.S. market wary of its history?

Vivos Inc. wins FDA approval for a human trial of RadioGel®, a targeted therapy that could offer new hope for patients with non-resectable thyroid cancer.

IceCure's ProSense™ is reshaping oncology in Brazil. A US FDA approval provided a critical tailwind, validating a less invasive future for cancer care.

Cerezen, a non-invasive device shown to reverse cognitive decline, has EU approval but remains in FDA limbo, raising questions about US patient access.

Amidst FDA warning letters and costly recalls, Integra LifeSciences appoints Topaz Kirlew as its new regulatory chief. It's a critical test of leadership.

Xeltis's bioabsorbable aXess graft hits a major US trial milestone, signaling a strategic shift in renal care away from failing synthetics to living tissue.

A milestone in digital dentistry is more than a number. It's a forensic look at a new industrial architecture for healthcare and its impact on every patient.

West's $112.5M sale of its 3.5mL device to AbbVie isn't a retreat. It's a strategic pivot to dominate the high-growth, large-volume drug delivery market.

A new partnership expands patient choice in Europe, but the real story is a strategic power play in the $100B+ diabetes market. Here’s why it matters.

After completing massive studies, the Utah firm is readying an FDA submission that could move gold-standard diagnostics from the lab to your local clinic.

A biotech firm is using the ISS to build artificial retinas, bypassing Earth's gravity to create a potential cure for millions facing blindness.

With €7.5M from Europe’s top innovation fund, a Belgian startup is not just correcting vision—it’s turning the eye into a window for our overall health.

A Singapore-based company has patented a device to end large incisions in colorectal surgery, promising fewer infections and faster patient recovery.

STARMED secures a landmark FDA clearance for its thyroid RFA system, the first of its kind, promising a minimally invasive alternative to surgery.

The global MRI market is shifting from a hardware race to a software game. AI, low-helium systems, and workflow automation are the new keys to success.